Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma. Arch Ital Urol Androl [Internet]. 2025 Jun. 16 [cited 2026 Jun. 5];97(2). Available from: https://www.pagepressjournals.org/aiua/article/view/13880